mforn@aniling.com

News

Aniling has presented GEUS-CLL and GEUS-CRC in the Cell-NCI Symposium: Beyond Cancer Genomics Toward Precision Oncology

Aniling has attended “The Cell-NCI Symposium: Beyond Cancer Genomics Toward Precision Oncology” organized by the Cell Press and the National Cancer Institute (NCI). Sheila Santín has presented the advances of …

News

Aniling has presented GEUS-CLL in the International Workshop of Chronic Lymphocytic Leukemia (iwCLL2021)

Aniling has attended to the International Workshop of Chronic Lymphocytic Leukemia (iwCLL2021), the biennial international meeting committed to advancing the field of CLL. Ester Cuenca has presented the advances of …

News

Aniling has reached the CE Mark for GEUS-CLL

We are very proud to announce that Aniling has reached the CE Mark for our first product, GEUS-CLL, a first-in-class IVD medical device to support the diagnosis, prognosis, treatment selection …

Author: mforn@aniling.com

Cookies